Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)
将治疗诊断靶点从前列腺特异性膜抗原 (PSMA) 合并为叶酸水解酶-1 (FOLH1)，并纳入性别和疾病相关的命名法。
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1304718
Ramirez-Fort, Marigdalia K; Gilman, Casey K; Alexander, Jacob S; Meier-Schiesser, Barbara; Gower, Arjan; Olyaie, Mojtaba; Vaidya, Neel; Vahidi, Kiarash; Li, Yuxin; Lange, Christopher S; Fort, Migdalia; Deurdulian, Corinne
